search
Back to results

Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery. (I-PEEP-THO)

Primary Purpose

Lung Diseases

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
"Open-lung" protective ventilation strategy
"Standard" protective ventilation strategy
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Lung Diseases focused on measuring Pulmonary resection surgery, One lung ventilation, Positive end-expiratory pressure, Esophageal pressure, Transpulmonary pressure, Lung compliance, Protective ventilation, Hypoxemia, Postoperative complications

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • To be over 18 years old,
  • To be able to attend all scheduled visits and to comply with all trial procedures,
  • To be scheduled for a lung cancer resection surgery (performed by either video-assisted thoracoscopy or thoracotomy).

Exclusion Criteria:

  • Non-carcinologic indication of lung resection (e.g. Lung volume reduction for bullous emphysema reduction, lung abscess),
  • Bilateral pulmonary resection surgery or history of lung resection surgery,
  • Lung resection under sternotomy
  • Contraindication to esophageal catheter (history of esophageal varices, hepatic cirrhosis child ≥ b, esophageal or gastric surgery, thoracic radiotherapy, latex allergy),
  • ASA (American Society of Anesthesiologists) score ≥ 4,
  • Chronic obstructive pulmonary disease GOLD III or IV (Forced Expiratory Volume, FEV<50%),
  • Uncontrolled asthma (FEV <50%),
  • Intracardiac shunt,
  • Hemoglobinopathy making the SpO2 values invalid,
  • Heart failure NYHA III or IV,
  • Documented pulmonary hypertension (Mean Pulmonary Arterial Pressure at rest, mPAP>20 mmHg),
  • To be under legal protection,
  • Unable to read or write,
  • Lack of informed consent, or unable to give consent,
  • Refusal to participate in the study,
  • Pregnancy in progress or planned during the study period, pregnant or nursing women,
  • Not being affiliated to a French social security system or being a beneficiary of such a system.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Experimental

    Arm Label

    "Standard" protective ventilation

    "Open lung" protective ventilation protocol

    Arm Description

    Patients receiving a positive-end expiratory pressure (PEEP) of 5 cmH2O

    Patients with a titrated positive-end expiratory pressure (PEEP) corresponding to the best lung compliance calculated with transpulmonary pressure.

    Outcomes

    Primary Outcome Measures

    The incidence of intraoperative hypoxemia
    A SpO2<92% while the FiO2 is progressively decreased to 50% according to a standardized algorithm.

    Secondary Outcome Measures

    Hypoxemia events
    The number of hypoxemia events, depth, and duration of hypoxemia.
    The ventilatory parameters
    Plateau pressure (mbar)
    The ventilatory parameters
    Driving PTP (cmH2O)
    The ventilatory parameters
    Airway driving pressure (cmH2O)
    The ventilatory parameters
    Lung compliance (ml/cmH2O)
    Blood gas analysis
    PaO2/FiO2 ratio (mmHg)
    Blood gas analysis
    PaCO2 (mmHg)
    Blood gas analysis
    pH
    Blood gas analysis
    HCO3- (mmol/L)
    Intraoperative events related to hypoxemia
    Additional recruitment maneuvers (cmH2O)
    Intraoperative events related to hypoxemia
    Additional bronchoscopy
    Intraoperative events related to hypoxemia
    Application of a selective PEEP to the operated lung using an auxiliary valve
    Intraoperative events related to hypoxemia
    Re-expansion and ventilation of the operated lung performed for hypoxemia
    Intraoperative events not only due to hypoxemia
    Atrial fibrillation (bpm), hypotension defined by systolic arterial pressure < 90 mmHg, needs for vasopressor,
    Postoperative respiratory complications until postoperative day 28
    Acute respiratory distress syndrome (ARDS) (diagnosed according to the Berlin definition), atelectasis or pleural effusion (documented on a postoperative chest radiograph), pneumonia (postoperative fever combined with an evocating chest radiograph, requiring antibiotics, with or without microbiologic confirmation), need for prolonged oxygen therapy (> 48 hours), need for high-flow nasal oxygen therapy, needs for postoperative invasive or noninvasive mechanical ventilation
    Non-respiratory postoperative complications until postoperative day-28 (POD28)
    Cardiovascular events such as myocardial infarction (troponin > threshold, combined with EKG modification or chest pain) or new-onset of atrial fibrillation (if the cardiac rhythm was sinus before surgery), acute kidney injury (defined by an AKIN stage ≥ 1), stroke (with CT scan or MRI confirmation) or transient ischemic attack, delirium (acutely disturbed state of mind)
    The hospital stay
    The in-hospital length of stay and hospital free-days at POD28, the hospital re-admission, ICU admission, and mortality at POD28 and POD90.

    Full Information

    First Posted
    August 26, 2022
    Last Updated
    May 26, 2023
    Sponsor
    University Hospital, Montpellier
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05525312
    Brief Title
    Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.
    Acronym
    I-PEEP-THO
    Official Title
    Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery: "Open Lung" Approach With Individualized Level of Positive End-expiratory Pressure Titrated According to the Best Lung Compliance, Versus "Standard" Care: a Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2023 (Anticipated)
    Primary Completion Date
    October 1, 2023 (Anticipated)
    Study Completion Date
    June 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Hospital, Montpellier

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    During thoracic surgery, one-lung ventilation (OLV) is associated with hypoxemia, lung injury, and perioperative respiratory complications. The level of positive-end expiratory pressure (PEEP) to apply during OLV remains controversial. The open-lung approach consists in setting a level of PEEP corresponding to the best lung compliance, using an esophageal catheter to measure the transpulmonary pressure. This approach has been effective in laparoscopic surgeries or acute respiratory distress syndrome, but has never been evaluated in thoracic surgery.
    Detailed Description
    Pulmonary resection surgery plays a key role in the treatment of localized lung cancer. During thoracic surgery, lung isolation is necessary. One-lung ventilation (OLV) is associated with frequent intraoperative respiratory complications, hypoxemia or lung injury related to mechanical ventilation. Intraoperative events increase the risk of postoperative complications resulting from either hypoxemia (atrial fibrillation, delirium, acute kidney injury) or lung injury (atelectasis, pulmonary edema, pneumonia, acute respiratory distress syndrome (ARDS)). During OLV, a protective ventilation strategy is now recommended, including a low tidal volume (VT), using the lowest fraction of inspired oxygen (FiO2) due to the toxicity of high-oxygen concentration, and recruitment maneuvers (RM). But there is no consensus on the level of positive end-tidal pressure (PEEP) to apply. A low level of PEEP increases the risk of alveolar collapse, when a too high level leads to alveolar overdistension and increases lung dead space. The PEEP is usually arbitrary fixed to 5 cmH2O for every patient, which does not take into account the individual characteristics of the patient. Recent clinical trials in thoracic surgery showed that titration of PEEP according to the lowest airway driving pressure [end-inspiratory plateau pressure - total end-expiratory pressure], compared to a standard PEEP of 5 cmH2O, increased oxygenation and lung mechanics, and decreased significantly respiratory complications. The transpulmonary pressure (PTP) is the instantaneous difference between alveolar pressure and pleural pressure. In order to optimize the alveolocapillary gas exchange, the level of PEEP should be titrated until achieving the best lung compliance (CL), defined by the ratio [(tidal volume) / (driving PTP = end-inspiratory PTP - end-expiratory PTP)]. As the tidal volume is set on the ventilator, the level of PEEP corresponding to the best CL is the one associated with the lowest driving PTP. The "open lung" strategy consists in setting the level of PEEP according to the best CL, which is an individualized approach, probably more physiologic than the standard care. The esophageal pressure (PES) measured by an esophageal catheter is a validated estimation of the pleural pressure. Then, the PTP could be approximated by the difference [airway plateau pressure - PES]. The placement of an esophageal catheter is safe provided that the use respects contraindications (mainly esophageal disease or varices). In ARDS, the open lung approach using an esophageal catheter was associated with a better clinical outcome than the standard non-individualized protocol. In laparoscopic surgery, the effects of PEEP on the PTP is also well described. In thoracic surgery, to date, monitoring PES and PTP is not part of the usual care. To our knowledge, only one study described the PTP changes during OLV. In this study, the best PEEP during OLV differed from one patient to another, which goes against the "one size fits all" theory. Thus, the PEEP should be titrated and individualized. Nevertheless, the airway driving pressure is only an approximation of the PTP, since it does not take into account the pleural pressure, which is a non-negligible extra-alveolar factor when talking about patients with lung or pleural diseases. Measuring the driving PTP using an esophageal catheter is certainly more accurate.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lung Diseases
    Keywords
    Pulmonary resection surgery, One lung ventilation, Positive end-expiratory pressure, Esophageal pressure, Transpulmonary pressure, Lung compliance, Protective ventilation, Hypoxemia, Postoperative complications

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    the "standard" protective ventilation versus an "open lung" protective ventilation protocol during a pulmonary resection surgery
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    120 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    "Standard" protective ventilation
    Arm Type
    Other
    Arm Description
    Patients receiving a positive-end expiratory pressure (PEEP) of 5 cmH2O
    Arm Title
    "Open lung" protective ventilation protocol
    Arm Type
    Experimental
    Arm Description
    Patients with a titrated positive-end expiratory pressure (PEEP) corresponding to the best lung compliance calculated with transpulmonary pressure.
    Intervention Type
    Procedure
    Intervention Name(s)
    "Open-lung" protective ventilation strategy
    Intervention Description
    In the "open-lung" group, the positive end-tidal pressure (PEEP) is titrated to match the best lung compliance. During a "PEEP decrement trial", PEEP is decreased from 20 cmH2O to 4 cmH2O by steps of 2 cmH2O/minute, and the driving the transpulmonary pressure (PTP) is calculated at each level of PEEP. In the "open-lung" group, the targeted PEEP corresponds to the lowest driving PTP during the "PEEP decrement trial", meaning the best lung compliance. Thereafter, the PEEP is set at this level and maintained until extubation.
    Intervention Type
    Procedure
    Intervention Name(s)
    "Standard" protective ventilation strategy
    Intervention Description
    In the "standard" group, the positive end-tidal pressure (PEEP) is arbitrarily set at 5 cmH2O, since this is the currently recommended level of PEEP, commonly used in control groups of previous clinical trials.
    Primary Outcome Measure Information:
    Title
    The incidence of intraoperative hypoxemia
    Description
    A SpO2<92% while the FiO2 is progressively decreased to 50% according to a standardized algorithm.
    Time Frame
    During the Open-Lung Ventilation (OLV) period
    Secondary Outcome Measure Information:
    Title
    Hypoxemia events
    Description
    The number of hypoxemia events, depth, and duration of hypoxemia.
    Time Frame
    During the OLV period
    Title
    The ventilatory parameters
    Description
    Plateau pressure (mbar)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    The ventilatory parameters
    Description
    Driving PTP (cmH2O)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    The ventilatory parameters
    Description
    Airway driving pressure (cmH2O)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    The ventilatory parameters
    Description
    Lung compliance (ml/cmH2O)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    Blood gas analysis
    Description
    PaO2/FiO2 ratio (mmHg)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    Blood gas analysis
    Description
    PaCO2 (mmHg)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    Blood gas analysis
    Description
    pH
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    Blood gas analysis
    Description
    HCO3- (mmol/L)
    Time Frame
    T1: baseline, two-lung ventilation, before OLV ; T2: 45 minutes after OLV ; T3: at the end of OLV, before re-expansion and ventilation of the operated lung ; T4: at the end of surgery, before extubation
    Title
    Intraoperative events related to hypoxemia
    Description
    Additional recruitment maneuvers (cmH2O)
    Time Frame
    During the OLV period
    Title
    Intraoperative events related to hypoxemia
    Description
    Additional bronchoscopy
    Time Frame
    During the OLV period
    Title
    Intraoperative events related to hypoxemia
    Description
    Application of a selective PEEP to the operated lung using an auxiliary valve
    Time Frame
    During the OLV period
    Title
    Intraoperative events related to hypoxemia
    Description
    Re-expansion and ventilation of the operated lung performed for hypoxemia
    Time Frame
    During the OLV period
    Title
    Intraoperative events not only due to hypoxemia
    Description
    Atrial fibrillation (bpm), hypotension defined by systolic arterial pressure < 90 mmHg, needs for vasopressor,
    Time Frame
    During the OLV period
    Title
    Postoperative respiratory complications until postoperative day 28
    Description
    Acute respiratory distress syndrome (ARDS) (diagnosed according to the Berlin definition), atelectasis or pleural effusion (documented on a postoperative chest radiograph), pneumonia (postoperative fever combined with an evocating chest radiograph, requiring antibiotics, with or without microbiologic confirmation), need for prolonged oxygen therapy (> 48 hours), need for high-flow nasal oxygen therapy, needs for postoperative invasive or noninvasive mechanical ventilation
    Time Frame
    Day 28
    Title
    Non-respiratory postoperative complications until postoperative day-28 (POD28)
    Description
    Cardiovascular events such as myocardial infarction (troponin > threshold, combined with EKG modification or chest pain) or new-onset of atrial fibrillation (if the cardiac rhythm was sinus before surgery), acute kidney injury (defined by an AKIN stage ≥ 1), stroke (with CT scan or MRI confirmation) or transient ischemic attack, delirium (acutely disturbed state of mind)
    Time Frame
    Day 28
    Title
    The hospital stay
    Description
    The in-hospital length of stay and hospital free-days at POD28, the hospital re-admission, ICU admission, and mortality at POD28 and POD90.
    Time Frame
    Day 28 and Day 90

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: To be over 18 years old, To be able to attend all scheduled visits and to comply with all trial procedures, To be scheduled for a lung cancer resection surgery (performed by either video-assisted thoracoscopy or thoracotomy). Exclusion Criteria: Non-carcinologic indication of lung resection (e.g. Lung volume reduction for bullous emphysema reduction, lung abscess), Bilateral pulmonary resection surgery or history of lung resection surgery, Lung resection under sternotomy Contraindication to esophageal catheter (history of esophageal varices, hepatic cirrhosis child ≥ b, esophageal or gastric surgery, thoracic radiotherapy, latex allergy), ASA (American Society of Anesthesiologists) score ≥ 4, Chronic obstructive pulmonary disease GOLD III or IV (Forced Expiratory Volume, FEV<50%), Uncontrolled asthma (FEV <50%), Intracardiac shunt, Hemoglobinopathy making the SpO2 values invalid, Heart failure NYHA III or IV, Documented pulmonary hypertension (Mean Pulmonary Arterial Pressure at rest, mPAP>20 mmHg), To be under legal protection, Unable to read or write, Lack of informed consent, or unable to give consent, Refusal to participate in the study, Pregnancy in progress or planned during the study period, pregnant or nursing women, Not being affiliated to a French social security system or being a beneficiary of such a system.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Hélène Dr DAVID
    Phone
    06.65.84.95.24
    Ext
    +33
    Email
    h-david@chu-montpellier.fr

    12. IPD Sharing Statement

    Learn more about this trial

    Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.

    We'll reach out to this number within 24 hrs